HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Vigneron Selected Research

Tyrosine Kinase Inhibitors

9/2022Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Vigneron Research Topics

Disease

1Frailty
09/2022
1Hepatocellular Carcinoma (Hepatoma)
09/2022
1Cholangiocarcinoma
09/2022

Drug/Important Bio-Agent (IBA)

1Sorafenib (BAY 43-9006)FDA Link
09/2022
1Tyrosine Kinase InhibitorsIBA
09/2022
1PlatinumIBA
09/2022

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2022